Matthew Truesdale, MD, FACS, discusses validation data showing that IsoPSA improves risk stratification for clinically significant prostate cancer in men with elevated PSA both with and without pre-biopsy mpMRI.
Matthew Truesdale, MD, FACS
Advertisement
Articles by Matthew Truesdale, MD, FACS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
Published VAPOR 2 data evaluate water vapor ablation for localized prostate cancer
2
From OR to office: How Break Wave changes urology practice workflow
3
Treatment Intensification in Metastatic Castration-Sensitive Prostate Cancer
4
Pearls & Perspectives: Advancing Erectile Dysfunction Research, with Nicholas Deebel, MD
5